T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Five Below
FIVE
$13.4B
| $90.1M | 0.01% |
692,951
-29,340
| -4% | -$3.26M |
|
|
HA
702
DELISTED
Hawaiian Holdings, Inc.
HA
| $89.3M | 0.01% |
2,226,305
+495,165
| +29% | +$19.7M |
|
703
Lazard
LAZ
$4.32B
| $89M | 0.01% |
1,848,897
-34,734
| -2% | -$1.73M |
|
704
Snap-on
SNA
$20.9B
| $89M | 0.01% |
484,503
-4,056
| -0.8% | -$707K |
|
705
AZZ Inc
AZZ
$4.55B
| $88.8M | 0.01% |
1,757,943
-163,143
| -8% | -$8.71M |
|
706
Clorox
CLX
$12.7B
| $88.7M | 0.01% |
589,609
-3,410
| -0.6% | -$484K |
|
707
Luxfer Holdings
LXFR
$457M
| $88.3M | 0.01% |
3,796,115
+341,370
| +10% | +$7.02M |
|
708
LCI Industries
LCII
$2.6B
| $88M | 0.01% |
1,063,059
-17,699
| -2% | -$1.66M |
|
709
Tyler Technologies
TYL
$12.8B
| $87.9M | 0.01% |
358,809
-1,172
| -0.3% | -$279K |
|
710
Universal Health Services
UHS
$10.1B
| $87.6M | 0.01% |
685,150
-59,910
| -8% | -$7.35M |
|
|
CSW
711
CSW Industrials
CSW
$5.64B
| $87.5M | 0.01% |
1,630,268
+484,702
| +42% | +$26.4M |
|
712
Autodesk
ADSK
$51.8B
| $87.2M | 0.01% |
558,527
+17,664
| +3% | +$2.49M |
|
713
Wintrust Financial
WTFC
$10.9B
| $87.1M | 0.01% |
1,025,620
-61,005
| -6% | -$5.43M |
|
714
Inogen
INGN
$155M
| $86.5M | 0.01% |
354,148
+753
| +0.2% | +$174K |
|
|
BHBK
715
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $86.4M | 0.01% |
3,584,038
+22,536
| +0.6% | +$512K |
|
716
Grupo Aval
AVAL
$6.47B
| $86.3M | 0.01% |
11,115,595
+1,168,245
| +12% | +$9.25M |
|
|
AEGN
717
DELISTED
Aegion Corp
AEGN
| $85.2M | 0.01% |
3,355,626
+25,447
| +0.8% | +$635K |
|
718
Harmonic Inc
HLIT
$1.39B
| $85M | 0.01% |
15,448,029
+123,234
| +0.8% | +$615K |
|
719
Red Robin
RRGB
$189M
| $84.9M | 0.01% |
2,114,989
+38,934
| +2% | +$1.66M |
|
720
Wave Life Sciences
WVE
$1.04B
| $84.7M | 0.01% |
1,693,892
+32,041
| +2% | +$1.45M |
|
721
Conduent
CNDT
$244M
| $84.3M | 0.01% |
3,744,539
-687,851
| -16% | -$14.1M |
|
722
Moody's
MCO
$83B
| $84.2M | 0.01% |
503,534
+9,587
| +2% | +$1.69M |
|
723
Plains GP Holdings
PAGP
$5.03B
| $83.6M | 0.01% |
3,407,085
-5,941,832
| -64% | -$147M |
|
724
Ligand Pharmaceuticals
LGND
$5.73B
| $83.5M | 0.01% |
487,496
+20,916
| +4% | +$3.15M |
|
|
AZPN
725
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $83.1M | 0.01% |
729,803
-2,165
| -0.3% | -$247K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.